While these features have long been attributed to obesity, inflammation, and dysfunctional insulin signaling [1], increasing evidence over the past two decades has highlighted a central role of the gastrointestinal tract in T2DM pathogenesis. The gene discussed is INS; the disease is type 2 diabetes mellitus.